サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1458769

全ゲノムおよびエクソームシーケンシングの世界市場レポート 2024年

Whole Genome And Exome Sequencing Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
全ゲノムおよびエクソームシーケンシングの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

全ゲノムおよびエクソームシーケンシング市場規模は、今後数年で飛躍的な成長が見込まれます。2028年にはCAGR24.8％で49億1,000万米ドルに成長します。予測期間中に予想される成長は、集団ゲノミクスへの取り組み、精密医療への需要の高まり、シングルセルシーケンシングの進歩、非侵襲的出生前検査（NIPT）の拡大、希少疾患研究への応用によってもたらされます。この期間に予想される主な動向には、臨床採用の増加、シーケンシング技術の急速な進歩、集団規模のゲノム研究の台頭、人工知能（AI）と機械学習（ML）の統合、腫瘍学への応用拡大などがあります。

個別化医療への関心の高まりは、今後数年間の全ゲノムおよびエクソームシーケンシング市場の拡大を促進すると予想されます。個別化医療は、遺伝、環境、ライフスタイルなどの患者個人の特性を考慮したオーダーメイドのアプローチをヘルスケアに採用し、治療の意思決定を行うものです。全ゲノムおよびエクソームシーケンシングは、個人の遺伝的構成を包括的に分析し、特定の遺伝的、環境的、ライフスタイル的要因に合わせてカスタマイズされたヘルスケア介入を可能にすることで、個別化医療において極めて重要な役割を果たしています。例えば、2022年10月の時点で、個別化医療連合（PMC）は75,000以上の遺伝子検査製品と300以上の個別化医薬品が市場に出回ると予測しています。さらに、米食品医薬品局（FDA）の医薬品評価研究センター（CDER）は2022年に37の新規分子化合物（NME）を承認し、35の治療用NMEのうち約34%が個別化医療に分類されます。その結果、個別化医療に対する需要の高まりが全ゲノムおよびエクソームシーケンシング市場の拡大に拍車をかけています。

全ゲノムおよびエクソームシーケンシング市場の主要企業は、競争優位性を獲得するために、特に超高速NGS（次世代シーケンサー）分析など、最先端技術ソリューションの開拓に向けた取り組みを強化しています。この技術革新はNGSデータの迅速な処理を促進し、解析時間を大幅に短縮します。例えば、米国のバイオインフォマティクス企業QIAGEN Digital Insights（QDI）は2023年1月、超高速NGS解析プラットフォームを発表しました。このプラットフォームは、クラウドコンピューティング費用1ドルで全ゲノムをわずか25分で処理するなどの特徴を誇り、効率性、手頃な価格、拡張性を促進します。この技術的躍進により、ゲノムデータ解析のスピードとアクセシビリティが大幅に向上し、迅速な意思決定と個別化医療の普及を可能にすることで、全ゲノムおよびエクソームシーケンシング市場で重要な役割を果たしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の全ゲノムおよびエクソームシーケンシング市場、製品タイプ別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • キット
  • 機器
  • 世界の全ゲノムおよびエクソームシーケンシング市場、ワークフロー別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 全ゲノム配列解析（WGS）
  • 全エクソームシーケンス（WES）
  • 世界の全ゲノムおよびエクソームシーケンシング市場、アプリケーション別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 診断
  • がん
  • 単一遺伝子疾患
  • 糖尿病
  • 医薬品の発見と開発
  • 個別化医療
  • 農業と動物研究
  • その他のアプリケーション
  • 世界の全ゲノムおよびエクソームシーケンシング市場、エンドユーザー別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 研究センター
  • 学術機関および政府機関
  • 病院と診療所
  • 製薬およびバイオテクノロジー企業
  • その他のエンドユーザー

第7章 地域別・国別分析

  • 世界の全ゲノムおよびエクソームシーケンシング市場、地域別、実績および予測、2018～2023年、2023～2028年、2033年
  • 世界の全ゲノムおよびエクソームシーケンシング市場、国別、実績および予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 全ゲノムおよびエクソームシーケンシング市場の競合情勢
  • 全ゲノムおよびエクソームシーケンシング市場の企業プロファイル
    • Siemens AG
    • Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Cytiva（Danaher Corporation）
    • Laboratory Corporation of America Holdings（Labcorp）

第31章 その他の大手企業と革新的企業

  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Canon Medical Systems Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Neusoft Corporation
  • BGI Genomics
  • Mirion Technologies（Capintec）Inc.
  • Novogene Co.
  • Oxford Nanopore Technologies Inc.
  • LANDAUER
  • Pacific Biosciences of California Inc.
  • Digirad Corporation
  • Berthold Technologies GmbH &Co.KG

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的分析

第36章 付録

目次
Product Code: r16751

Whole genome sequencing (WGS) and exome sequencing (ES) are advanced genetic analysis methodologies aimed at deciphering an organism's complete DNA sequence and specifically targeting the protein-coding regions of the genome. These techniques play a crucial role in diagnosing genetic disorders and identifying cancer-related mutations.

The primary product categories in WGS and ES comprise kits and instruments, where kits encompass a collection of related products packaged together for simplified inventory management. Various workflows such as whole genome sequencing (WGS) and whole exome sequencing (WES) are utilized across multiple applications including diagnostics, cancer research, monogenic disorders, drug development, personalized medicine, agriculture, and animal research. End users encompass diverse entities such as research centers, academic institutions, governmental bodies, hospitals, pharmaceutical and biotechnology companies, among others.

The whole genome and exome sequencing market research report is one of a series of new reports from The Business Research Company that provides whole genome and exome sequencing market statistics, including whole genome and exome sequencing industry global market size, regional shares, competitors with a whole genome and exome sequencing market share, detailed whole genome and exome sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the whole genome and exome sequencing industry. This whole genome and exome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The whole genome and exome sequencing market size has grown exponentially in recent years. It will grow from $1.61 billion in 2023 to $2.02 billion in 2024 at a compound annual growth rate (CAGR) of 25.5%. The growth observed during the historical period can be ascribed to declining sequencing costs, an increase in genetic disorders, clinical applications, the establishment of genomic data repositories, and advancements in bioinformatics.

The whole genome and exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $4.91 billion in 2028 at a compound annual growth rate (CAGR) of 24.8%. The anticipated growth in the forecast period is driven by population genomics initiatives, increased demand for precision medicine, advancements in single-cell sequencing, expansion of non-invasive prenatal testing (NIPT), and its application in rare disease research. Key trends expected during this period include increased clinical adoption, rapid advancements in sequencing technologies, the rise of population-scale genomic studies, integration of artificial intelligence (AI) and machine learning (ML), and expanding applications in oncology.

The increasing interest in personalized medicine is anticipated to drive the expansion of the whole genome and exome sequencing market in the coming years. Personalized medicine adopts a tailored approach to healthcare, considering individual patient characteristics such as genetics, environment, and lifestyle in treatment decisions. Whole genome and exome sequencing play a pivotal role in personalized medicine by offering a comprehensive analysis of an individual's genetic composition, enabling healthcare interventions customized to their specific genetic, environmental, and lifestyle factors. For example, as of October 2022, the Personalized Medicine Coalition (PMC) projects over 75,000 genetic testing products and 300 personalized medicines to be available on the market. Additionally, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022, with approximately 34% classified as personalized among the 35 therapeutic NMEs. Consequently, the growing demand for personalized medicine is fueling the expansion of the whole genome and exome sequencing market.

Major players in the whole genome and exome sequencing markets are intensifying their efforts towards developing cutting-edge technological solutions, notably ultra-fast NGS (next-generation sequencing) analysis, to gain a competitive advantage. This innovation facilitates the rapid processing of NGS data, drastically reducing analysis time. For example, in January 2023, QIAGEN Digital Insights (QDI), a US-based bioinformatics company, introduced an ultra-fast NGS analysis platform. This platform boasts features such as processing a whole genome in just 25 minutes at a cost of $1 in cloud computing expenses, promoting efficiency, affordability, and scalability. Its technological breakthrough significantly enhances the speed and accessibility of genomic data analysis, playing a crucial role in the whole genome and exome sequencing market by enabling swift decision-making and wider adoption of personalized medicine.

In January 2023, QIAGEN, a multinational corporation headquartered in Germany and specializing in sample technologies and molecular insights products, acquired Verogen for an undisclosed sum. This acquisition bolsters QIAGEN's presence in the human identification and forensics market, consolidating its leadership position and facilitating the creation of more comprehensive solutions with potential implications for the entire genome and exome sequencing market. Verogen, based in the United States, is a biotech company that offers next-generation sequencing (NGS) tools and services, including whole genome and exome sequencing.

Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan.

North America was the largest region in the whole genome and exome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the whole genome and exome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The whole genome and exome sequencing market consists of revenues earned by entities by providing services such as genetic profiling, variant identification, personalized medicine solutions, and comprehensive genomic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The whole genome and exome sequencing market also includes sales of exome capture kits, benchtop sequencer, and sample preparation instrutments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Whole Genome And Exome Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on whole genome and exome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for whole genome and exome sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The whole genome and exome sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Kits; Instruments
  • 2) By Workflow: Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES)
  • 3) By Applications: Diagnostics; Cancer; Monogenic Disorders; Diabetes; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research; Other Applications
  • 4) By End user: Research Center; Academic And Government Institutions; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
  • Companies Mentioned: Siemens AG; Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Cytiva (Danaher Corporation); Laboratory Corporation of America Holdings (Labcorp)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Whole Genome And Exome Sequencing Market Characteristics

3. Whole Genome And Exome Sequencing Market Trends And Strategies

4. Whole Genome And Exome Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Whole Genome And Exome Sequencing Market Size and Growth

  • 5.1. Global Whole Genome And Exome Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Whole Genome And Exome Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Whole Genome And Exome Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Whole Genome And Exome Sequencing Market Segmentation

  • 6.1. Global Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Kits
  • Instruments
  • 6.2. Global Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • 6.3. Global Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Cancer
  • Monogenic Disorders
  • Diabetes
  • Drug Discovery And Development
  • Personalized Medicine
  • Agriculture And Animal Research
  • Other Applications
  • 6.4. Global Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research Center
  • Academic And Government Institutions
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End Users

7. Whole Genome And Exome Sequencing Market Regional And Country Analysis

  • 7.1. Global Whole Genome And Exome Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Whole Genome And Exome Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Whole Genome And Exome Sequencing Market

  • 8.1. Asia-Pacific Whole Genome And Exome Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Whole Genome And Exome Sequencing Market

  • 9.1. China Whole Genome And Exome Sequencing Market Overview
  • 9.2. China Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Whole Genome And Exome Sequencing Market

  • 10.1. India Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Whole Genome And Exome Sequencing Market

  • 11.1. Japan Whole Genome And Exome Sequencing Market Overview
  • 11.2. Japan Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Whole Genome And Exome Sequencing Market

  • 12.1. Australia Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Whole Genome And Exome Sequencing Market

  • 13.1. Indonesia Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Whole Genome And Exome Sequencing Market

  • 14.1. South Korea Whole Genome And Exome Sequencing Market Overview
  • 14.2. South Korea Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Whole Genome And Exome Sequencing Market

  • 15.1. Western Europe Whole Genome And Exome Sequencing Market Overview
  • 15.2. Western Europe Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Whole Genome And Exome Sequencing Market

  • 16.1. UK Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Whole Genome And Exome Sequencing Market

  • 17.1. Germany Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Whole Genome And Exome Sequencing Market

  • 18.1. France Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Whole Genome And Exome Sequencing Market

  • 19.1. Italy Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Whole Genome And Exome Sequencing Market

  • 20.1. Spain Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Whole Genome And Exome Sequencing Market

  • 21.1. Eastern Europe Whole Genome And Exome Sequencing Market Overview
  • 21.2. Eastern Europe Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Whole Genome And Exome Sequencing Market

  • 22.1. Russia Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Whole Genome And Exome Sequencing Market

  • 23.1. North America Whole Genome And Exome Sequencing Market Overview
  • 23.2. North America Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Whole Genome And Exome Sequencing Market

  • 24.1. USA Whole Genome And Exome Sequencing Market Overview
  • 24.2. USA Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Whole Genome And Exome Sequencing Market

  • 25.1. Canada Whole Genome And Exome Sequencing Market Overview
  • 25.2. Canada Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Whole Genome And Exome Sequencing Market

  • 26.1. South America Whole Genome And Exome Sequencing Market Overview
  • 26.2. South America Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Whole Genome And Exome Sequencing Market

  • 27.1. Brazil Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Whole Genome And Exome Sequencing Market

  • 28.1. Middle East Whole Genome And Exome Sequencing Market Overview
  • 28.2. Middle East Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Whole Genome And Exome Sequencing Market

  • 29.1. Africa Whole Genome And Exome Sequencing Market Overview
  • 29.2. Africa Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Whole Genome And Exome Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Whole Genome And Exome Sequencing Market Competitive Landscape
  • 30.2. Whole Genome And Exome Sequencing Market Company Profiles
    • 30.2.1. Siemens AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Cytiva (Danaher Corporation)
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings (Labcorp)
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Whole Genome And Exome Sequencing Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific SE
  • 31.2. Agilent Technologies Inc.
  • 31.3. Illumina Inc.
  • 31.4. Canon Medical Systems Corporation
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. QIAGEN N.V
  • 31.7. Neusoft Corporation
  • 31.8. BGI Genomics
  • 31.9. Mirion Technologies (Capintec) Inc.
  • 31.10. Novogene Co.
  • 31.11. Oxford Nanopore Technologies Inc.
  • 31.12. LANDAUER
  • 31.13. Pacific Biosciences of California Inc.
  • 31.14. Digirad Corporation
  • 31.15. Berthold Technologies GmbH & Co.KG

32. Global Whole Genome And Exome Sequencing Market Competitive Benchmarking

33. Global Whole Genome And Exome Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Whole Genome And Exome Sequencing Market

35. Whole Genome And Exome Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Whole Genome And Exome Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Whole Genome And Exome Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Whole Genome And Exome Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer